To ensure transparency, traceability and professional secrecy, the documentation related to joint scientific consultations on medical devices and in vitro diagnostic medical devices should be sent in a digital format and should be exchanged with and between the Coordination Group, the JSC Subgroup, the HTA Secretariat, the health technology developer, and individual experts during joint scientific consultations through the HTA IT platform.
Recital 18, Regulation (EU) 2025/117
In forcesince 24 Jan 2025